Literature DB >> 10094408

Protein kinase CK2-dependent regulation of p53 function: evidence that the phosphorylation status of the serine 386 (CK2) site of p53 is constitutive and stable.

L McKendrick1, D Milne, D Meek.   

Abstract

The p53 tumour suppressor protein is regulated by several mechanisms including multisite phosphorylation. One of the protein kinases which has an established role in regulating p53 function is the protein kinase CK2. The regulation by CK2 occurs both through interaction of p53 with CK2 itself (the regulatory beta subunit) and phosphorylation at the penultimate residue of p53, serine 386 (murine p53). Strikingly, this phosphorylation event controls several independent functions of p53 including site-specific DNA binding, strand renaturation, transcriptional repression and the anti-proliferative function of p53. However, CK2 is a constitutively-active enzyme and therefore the mechanism by which the phosphorylation of p53 at serine 386 is itself regulated, or indeed the question as to whether phosphorylation of this site is regulated at all, remains unresolved. In this paper we provide evidence that serine 386 is highly resistant to dephosphorylation in cultured cells, even though this site can be dephosphorylated in vitro by recombinant protein phosphatase 1. These data suggest that, once phosphorylated at the CK2 site, a p53 molecule remains in this modified form throughout its lifespan. To address the issue of whether the level of serine 386 phosphorylation may be regulated through controlling the subcellular compartmentalisation of p53 and CK2, we examined the subcellular localisation of p53 and CK2alpha in C57MG cells and Rat-1 fibroblasts by immunofluorescence staining. Both proteins were present in the cytoplasm and enriched in the nucleus, with minor variations in the intensity of subcellular location over the course of the cell cycle. Similarly, activation of p53 by UV irradiation or DNA damage-inducing drugs had no effect on either the localisation or levels of CK2alpha, even although significant nuclear p53 accumulation was observed. A striking observation arising from these studies was the intense staining of CK2alpha with the centrosomes, suggesting a potentially important role for this kinase in microtubule formation and/or chromosomal segregation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10094408

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  70 in total

1.  T antigen is bound to a host protein in SV40-transformed cells.

Authors:  D P Lane; L V Crawford
Journal:  Nature       Date:  1979-03-15       Impact factor: 49.962

2.  Phosphorylation of p53 in normal and simian virus 40-transformed NIH 3T3 cells.

Authors:  D W Meek; W Eckhart
Journal:  Mol Cell Biol       Date:  1988-01       Impact factor: 4.272

3.  Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus.

Authors:  J Jayaraman; C Prives
Journal:  Cell       Date:  1995-06-30       Impact factor: 41.582

4.  Use of the two-hybrid system to identify the domain of p53 involved in oligomerization.

Authors:  K Iwabuchi; B Li; P Bartel; S Fields
Journal:  Oncogene       Date:  1993-06       Impact factor: 9.867

5.  Wild-type p53 is a cell cycle checkpoint determinant following irradiation.

Authors:  S J Kuerbitz; B S Plunkett; W V Walsh; M B Kastan
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

6.  Human TAFII31 protein is a transcriptional coactivator of the p53 protein.

Authors:  H Lu; A J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

7.  p53 binds to the TATA-binding protein-TATA complex.

Authors:  D W Martin; R M Muñoz; M A Subler; S Deb
Journal:  J Biol Chem       Date:  1993-06-25       Impact factor: 5.157

8.  Negative feedback regulation of wild-type p53 biosynthesis.

Authors:  J Mosner; T Mummenbrauer; C Bauer; G Sczakiel; F Grosse; W Deppert
Journal:  EMBO J       Date:  1995-09-15       Impact factor: 11.598

9.  Accumulation of wild-type p53 protein upon gamma-irradiation induces a G2 arrest-dependent immunoglobulin kappa light chain gene expression.

Authors:  R Aloni-Grinstein; D Schwartz; V Rotter
Journal:  EMBO J       Date:  1995-04-03       Impact factor: 11.598

10.  p53-catalyzed annealing of complementary single-stranded nucleic acids.

Authors:  P Oberosler; P Hloch; U Ramsperger; H Stahl
Journal:  EMBO J       Date:  1993-06       Impact factor: 11.598

View more
  19 in total

1.  Localization of individual subunits of protein kinase CK2 to the endoplasmic reticulum and to the Golgi apparatus.

Authors:  M Faust; M Jung; J Günther; R Zimmermann; M Montenarh
Journal:  Mol Cell Biochem       Date:  2001-11       Impact factor: 3.396

Review 2.  Emergence of protein kinase CK2 as a key target in cancer therapy.

Authors:  Janeen H Trembley; Zhong Chen; Gretchen Unger; Joel Slaton; Betsy T Kren; Carter Van Waes; Khalil Ahmed
Journal:  Biofactors       Date:  2010 May-Jun       Impact factor: 6.113

3.  CK2 interacting proteins: emerging paradigms for CK2 regulation?

Authors:  Mary Ellen K Olsten; Jane E Weber; David W Litchfield
Journal:  Mol Cell Biochem       Date:  2005-06       Impact factor: 3.396

4.  Evidence for regulation of mitotic progression through temporal phosphorylation and dephosphorylation of CK2alpha.

Authors:  Nicole A St-Denis; D Richard Derksen; David W Litchfield
Journal:  Mol Cell Biol       Date:  2009-02-02       Impact factor: 4.272

5.  Contribution of the individual subunits of protein kinase CK2 and of hPrp3p to the splicing process.

Authors:  Janka Dörr; Sabine Kartarius; Claudia Götz; Mathias Montenarh
Journal:  Mol Cell Biochem       Date:  2008-06-14       Impact factor: 3.396

Review 6.  Induction and activation of the p53 pathway: a role for the protein kinase CK2?

Authors:  David W Meek; Miranda Cox
Journal:  Mol Cell Biochem       Date:  2011-07-19       Impact factor: 3.396

7.  DBC1 does not function as a negative regulator of SIRT1 in liver cancer.

Authors:  Hyun Jin Bae; Young Gyoon Chang; Ji Heon Noh; Jeong Kyu Kim; Jung Woo Eun; Kwang Hwa Jung; Min Gyu Kim; Qingyu Shen; Young Min Ahn; So Hee Kwon; Won Sang Park; Jung Young Lee; Suk Woo Nam
Journal:  Oncol Lett       Date:  2012-08-23       Impact factor: 2.967

8.  Casein kinase II phosphorylation regulates alphaNAC subcellular localization and transcriptional coactivating activity.

Authors:  Isabelle Quélo; Claude Gauthier; René St-Arnaud
Journal:  Gene Expr       Date:  2005

Review 9.  Protein kinase CK2 in health and disease: CK2: a key player in cancer biology.

Authors:  J H Trembley; G Wang; G Unger; J Slaton; K Ahmed
Journal:  Cell Mol Life Sci       Date:  2009-06       Impact factor: 9.261

10.  Development of a potent and selective chemical probe for the pleiotropic kinase CK2.

Authors:  Carrow I Wells; David H Drewry; Julie E Pickett; Amelie Tjaden; Andreas Krämer; Susanne Müller; Laszlo Gyenis; Daniel Menyhart; David W Litchfield; Stefan Knapp; Alison D Axtman
Journal:  Cell Chem Biol       Date:  2021-01-22       Impact factor: 8.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.